secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001193125-23-251090
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen's acquisition of Horizon Therapeutics sanctioned by Irish High Court
--------------------------------------------------------------------------

- Irish High Court sanctioned the scheme of arrangement on October 5, 2023, moving deal closer to completion.
- Completion remains subject to delivery of the court order to the Registrar of Companies in Ireland.
- Deal originally announced December 11, 2022, valued at ~$27.8B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312523251090/0001193125-23-251090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312523251090/d533762d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-251090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer